Table of Contents Nucynta ER Poses Lower Risk for Abuse than Other Opioids Results of the Study Resources and References: Nucynta ER Poses Lower Risk for Abuse than Other Opioids The risk for abuse was significantly lower among patients taking Nucynta extended-release than abuse-deterrent formulation opioids and non-abuse deterrent formulation extended-release opioids, according to data…
Table of Contents Using Norpramin (Desipramine) for Drug Withdrawal Cocaine Addiction Dosing of Norpramin Detox Is Norpramin Right for You? Resources and References: Using Norpramin (Desipramine) for Drug Withdrawal Cocaine Addiction Desipramine is an antidepressant that treats symptoms related to major depression, as well as neuropathic pain, ADHD, insomnia, and other problems. It is marketed…
Mysoline is the brand name for barbiturate primidone, an extremely potent sedative that was initially used to treat epilepsy, anxiety, insomnia, and other sleep disorders. Like other barbiturates, Mysoline is rarely prescribed today because of many harmful side effects associated with its use and its very high potential for abuse, addiction, and overdose. Presently, Mysoline…
Table of Contents Patients in The United States and Canada Are Likely to Receive Opium After Surgery Use of Opioids or Opium Resources and References: To compare international opium prescribing rates after surgery, researchers evaluated data on four frequently performed procedures: surgery to remove the appendix, surgery to remove the gallbladder, a minimally invasive procedure…
Table of Contents United States Hospitals Reporting Rise in Opiate Overdoses During COVID Pandemic Locations Reporting Rise in Overdoses Causes for Opiate Overdose Increases Actions States Can Take to Flatten the Curve Resources and References: All across the country, federal and local officials are reporting disturbing spikes in drug overdoses? — an epidemic hidden within…
Table of Contents FDA Requests Removal of Opana ER for Risks Related to Abuse Abuse and Manipulation of Opana ER Resources and References: Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medicine, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal…
Table of Contents FDA Approves New Onsolis Formulation Abuse and Risk of Fentanyl Resources and References: FDA has approved a new formulation of fentanyl buccal soluble film (Onsolis, BioDelivery Sciences International) CII for the management of breakthrough pain in cancer patients who are opioid-tolerant. Onsolis has fentanyl, an opioid agonist, in the form of a…
Table of Contents Federal Health Officials Seek a Balanced Approach to Prescribing Opioid-Norco Guide to Tapering Opioids Resources and References: Federal health officials released a guide for clinicians who are considering tapering patients’ Norco prescriptions, highlighting the benefits of safe reductions in dosages while warning against abrupt drops for people who have been on the…
Table of Contents Chronic Pain Is an Impossible Problem Neurontin Prescription Resources and References: A “safe” alternative to opioid painkillers turns out to be unsafe. Neurontin was supposed to be the answer. Chronic pain afflicts about a fifth of American adults, and for years, physicians thought it could be treated with prescription painkillers like Oxycontin.…
Table of Contents Nembutal Addiction Paths to Nembutal Abuse and Addiction Taking the Initial Step Resources and References: Non-medical use of prescription drugs has increased throughout the U.S. In 2007, more than 6 million people were using prescription drugs for non-medical purposes. Of these people, approximately 300,000 persons were using sedatives, such as Nembutal, for…
